Smartphone App Outperforms Traditional Coronary Angiography
By HospiMedica International staff writers Posted on 16 Apr 2018 |

Image: The Instant Heart Rate monitoring application (Photo courtesy of Azumio).
A smartphone application that assesses ulnar artery patency via photoplethysmography is diagnostically superior to traditional physical examination, according to a new study.
Researchers at the University of Ottawa (Canada), Mount Sinai Health System (MSHS; New York, NY, USA), and other institutions conducted a study in 438 patients in order to compare the use of the Azumio Instant Heart Rate monitoring application on an iPhone 4S to the modified Allen test, which measures blood flow in the radial and ulnar arteries of the wrist in order to evaluate the collateral circulation to the hand, and determine patient eligibility for radial artery access.
Study participants were split into two groups; one group was assessed using the app, and the other was assessed using the Allen test. All patients then underwent conventional plethysmography of the index finger, followed by Doppler ultrasonography of the radial and ulnar arteries. The primary outcome was diagnostic accuracy of the heart rate monitoring application. The results revealed that the Azumio app had a superior diagnostic accuracy (91.8%) than that of the modified Allen test (81.7%). The study was published on April 3, 2018, in the Canadian Medical Association Journal (CMAJ).
“Because of the widespread availability of smartphones, they are being used increasingly as point-of-care diagnostics in clinical settings with minimal or no cost,” said Benjamin Hibbert, MD, of the University of Ottawa Heart Institute. “For example, built-in cameras with dedicated software or photodiode sensors using infrared light-emitting diodes have the potential to render smartphones into functional plethysmographs.”
“When smartphones and apps begin to be used clinically, it is important that they are evaluated in the same rigorous manner by which we assess all therapies and diagnostic tests,” said lead author Pietro Di Santo, MD, of the University of Ottawa. “When we designed the study, we wanted to hold the technology to the highest scientific standards to make sure the data supporting its use was as robust as possible.”
Color Doppler ultrasonography imaging is the gold standard method for assessing arterial patency and collateral competency, but it is relatively resource-intensive and thus seldom feasible or cost-effective in routine clinical practice.
Related Links:
University of Ottawa
Mount Sinai Health System
Researchers at the University of Ottawa (Canada), Mount Sinai Health System (MSHS; New York, NY, USA), and other institutions conducted a study in 438 patients in order to compare the use of the Azumio Instant Heart Rate monitoring application on an iPhone 4S to the modified Allen test, which measures blood flow in the radial and ulnar arteries of the wrist in order to evaluate the collateral circulation to the hand, and determine patient eligibility for radial artery access.
Study participants were split into two groups; one group was assessed using the app, and the other was assessed using the Allen test. All patients then underwent conventional plethysmography of the index finger, followed by Doppler ultrasonography of the radial and ulnar arteries. The primary outcome was diagnostic accuracy of the heart rate monitoring application. The results revealed that the Azumio app had a superior diagnostic accuracy (91.8%) than that of the modified Allen test (81.7%). The study was published on April 3, 2018, in the Canadian Medical Association Journal (CMAJ).
“Because of the widespread availability of smartphones, they are being used increasingly as point-of-care diagnostics in clinical settings with minimal or no cost,” said Benjamin Hibbert, MD, of the University of Ottawa Heart Institute. “For example, built-in cameras with dedicated software or photodiode sensors using infrared light-emitting diodes have the potential to render smartphones into functional plethysmographs.”
“When smartphones and apps begin to be used clinically, it is important that they are evaluated in the same rigorous manner by which we assess all therapies and diagnostic tests,” said lead author Pietro Di Santo, MD, of the University of Ottawa. “When we designed the study, we wanted to hold the technology to the highest scientific standards to make sure the data supporting its use was as robust as possible.”
Color Doppler ultrasonography imaging is the gold standard method for assessing arterial patency and collateral competency, but it is relatively resource-intensive and thus seldom feasible or cost-effective in routine clinical practice.
Related Links:
University of Ottawa
Mount Sinai Health System
Latest Health IT News
- Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
- Smartwatches Could Detect Congestive Heart Failure
- Versatile Smart Patch Combines Health Monitoring and Drug Delivery
- Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients
- Strategic Collaboration to Develop and Integrate Generative AI into Healthcare
- AI-Enabled Operating Rooms Solution Helps Hospitals Maximize Utilization and Unlock Capacity
- AI Predicts Pancreatic Cancer Three Years before Diagnosis from Patients’ Medical Records
- First Fully Autonomous Generative AI Personalized Medical Authorizations System Reduces Care Delay
- Electronic Health Records May Be Key to Improving Patient Care, Study Finds
- AI Trained for Specific Vocal Biomarkers Could Accurately Predict Coronary Artery Disease
- First-Ever AI Test for Early Diagnosis of Alzheimer’s to Be Expanded to Diagnosis of Parkinson’s Disease
Channels
Artificial Intelligence
view channel
Innovative Risk Score Predicts Heart Attack or Stroke in Kidney Transplant Candidates
Heart researchers have utilized an innovative risk assessment score to accurately predict whether patients being evaluated for kidney transplants are at risk for future major cardiac events, such as a... Read more
AI Algorithm Detects Early-Stage Metabolic-Associated Steatotic Liver Disease Using EHRs
Liver disease, which is treatable when detected early, often goes unnoticed until it reaches advanced stages. Metabolic-associated steatotic liver disease (MASLD), the most prevalent form of liver disease,... Read moreCritical Care
view channel
Novel Coating Significantly Extends Longevity of Implantable Biosensors
Wearable and implantable biosensors capable of accurately detecting biological molecules in a non-invasive or minimally invasive way offer enormous potential for monitoring patients’ health and their responses... Read more
Nanogel-Based Drug Delivery Technology to Improve UTI Treatment
Urinary tract infections (UTIs) are not only widespread and costly but also highly debilitating, significantly impacting the quality of life for those affected. The antibiotics commonly used to treat UTIs... Read more
New IV Pole Improves Safety and Ease of Administering IV Medications at Hospital Bedside
Preventable medication errors affect around 500,000 hospitalized patients in the U.S. every year. A significant portion of these errors occur with intravenous (IV) smart pumps, which require a precise... Read moreSurgical Techniques
view channel
Easy-To-Apply Gel Could Prevent Formation of Post-Surgical Abdominal Adhesions
Surgical adhesions are a frequent and often life-threatening complication following open or laparoscopic abdominal surgery. These adhesions develop in the weeks following surgery as the body heals.... Read more
Groundbreaking Leadless Pacemaker to Prevent Invasive Surgeries for Children
Leadless pacemakers marked a significant advancement in cardiac care, primarily because traditional pacemakers are dependent on leads, which are prone to breakage over time. Currently, two FDA-approved... Read morePatient Care
view channel
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read morePoint of Care
view channel
Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour
Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Smartphone-Enabled, Paper-Based Quantitative Diagnostic Platform Transforms POC Testing
Point-of-care diagnostics are crucial for public health, offering rapid, on-site testing that enables prompt diagnosis and treatment. This is especially valuable in remote or underserved regions where... Read moreBusiness
view channel
Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
Becton, Dickinson and Company (BD, Franklin Lakes, NJ, USA), has announced that its board of directors has unanimously authorized BD management to pursue a plan to separate BD's Biosciences and Diagnostic... Read more